Work

Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.8_suppl.138

Authors: Jesus Vera Aguilera, Jonas Paludo, Jarrett Failing, Robert R. McWilliams, Lisa A. Kottschade, Matthew Stephen Block, Svetomir Markovic, Roxana Stefania Dronca, Yiyi Yan

Institution: Mayo Clinic

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4231805749

Cites:

Cited by:

Related to: 10